kwic
due+to
due+to
right
off
ON
137
1
100
500
strict
ELIZA cgi-bash version rev. 1.91
- Medical English LInking keywords finder for the PubMed Zipped Archive (ELIZA) -
return
kwic search for due to out of >500 occurrences
319715 occurrences (No.67 in the rank) during 5 years in the PubMed. [cache]
--- ABSTRACT ---
--- ABSTRACT END ---
[frequency of next (right) word to due to]
319715 occurrences (No.67 in the rank) during 5 years in the PubMed. [cache]
| 137) Starch nanoparticles (SNPs) have been applied to different areas of material sciences, especially in pharmaceuticals due to their characteristics such as small particle size, high surface ratio-volume, and biological compatibility. |
| PMID:33766602 DOI:10.1016/j.ijbiomac.2021.03.061 |
| 2021 International journal of biological macromolecules |
| * Pharmaceutical applications of starch nanoparticles: A scoping review. |
| - Starch nanoparticles (SNPs) have been applied to different areas of material sciences, especially in pharmaceuticals due to their characteristics such as small particle size, high surface ratio-volume, and biological compatibility. However, in pharmaceutical sciences, there are no records of a scoping review that had extensively mapped all available information about SNPs. A scoping review was performed here by searching electronic databases (Pubmed and Science Direct) to identify studies published previous to June 2020. From 699 total records, 37 matched the criteria for inclusion. The findings showed that SNPs have been used, not only for the development of different active pharmaceutical ingredient delivery systems, but also as an enzyme inhibitor, adsorption, and DNA precipitation agent. In conclusion, by combining different starch sources and methods SNPs show a remarkable diversity in pharmaceutical applications. Future studies should explore SNPs safety and provide information about variables that may affect important properties for this kind of application. |
[
right
kwic]
(1)131  the |
(10)4 low |
(19)2 climate |
(28)2 non-PCV13 |
| (2)43 their |
(11)3 heterogeneity |
(20)2 confounding |
(29)2 placebo |
| (3)28 its |
(12)3 increased |
(21)2 decreased |
(30)2 pulmonary |
| (4)21 a |
(13)3 lack |
(22)2 different |
(31)2 stigma |
| (5)6 an |
(14)3 other |
(23)2 exposure-induced |
(32)2 substance |
| (6)5 COVID-19 |
(15)3 technical |
(24)2 factors |
(33)2 treatment |
| (7)5 poor |
(16)2 CMDs |
(25)2 functional |
(34)2 uncertainty |
| (8)4 allergy, |
(17)2 acute |
(26)2 incomplete |
|
| (9)4 high |
(18)2 age, |
(27)2 limited |
add keyword
--- WordNet output for due ---